Purpose: Postoperative nausea and vomiting (PONV) and post-discharge nausea and vomiting (PDNV) continue to be common and disturbing complications experienced after surgery, particularly in women and especially in women undergoing breast cancer surgery. The purpose of this study was to assess the incidence and risk factors associated with PONV and PDNV from preoperative to 48 hours postoperatively in 97 women scheduled for breast cancer surgery. Design: Prospective, comparative design. Methods: After informed consent was obtained, women scheduled for breast cancer surgery were evaluated for incidence of vomiting, as well as the presence and severity of nausea from the preoperative holding area for 48 hours following surgery. Vomiting was assessed as both a nominally scaled, binary variable (Yes/No) and as a continuous variable to measure separate emetic events. Nausea was measured on an 11point verbal numeric scale with 0 being the absence of nausea and 10 representing the highest level of nausea ever experienced. Results: Twenty-nine (29.8%) women experienced nausea, and nine (9%) women experienced nausea and vomiting while in the post-anesthesia care unit despite close attention to the need for prophylactic antiemetic medications. Women who experienced PONV had higher levels of pain and received more opioids than those women who did not experience PONV. Women who received intravenous acetaminophen did not experience less PONV in this study. PDNV occurred more frequently than PONV, with 34 women (35%) reporting occurrence after discharge. About 13 women who did not experience PONV while in the PACU subsequently experienced PDNV after leaving the hospital, evidence for the importance of patient discharge teaching regarding these symptoms. Although clinical guidelines are necessary, our observation is that nurses in the PACU setting continuously challenge themselves to individualize the
combination of medications and activities for each patient to reduce PONV after surgery.
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Ó 2016 by American Society of PeriAnesthesia Nurses POSTOPERATIVE NAUSEA AND VOMITING (PONV) continues to be one of the most common and disturbing complications patients experience after surgery, particularly for women undergoing cancer surgery. [1] [2] [3] The incidence of PONV after breast cancer surgery has been reported to be as high as 80%. [4] [5] [6] Because 232,670 women are expected to be diagnosed with breast cancer in 2015 and most will undergo surgery as part of their curative treatment, PONV in this population is a highly significant clinical problem. 7 PONV has a profound impact on the health and wellbeing of women with breast cancer and is related to significant morbidity (dehydration, wound dehiscence, pain, and immobility), 8 delayed discharge from the postanesthesia care unit (PACU), increased length of hospital stay, increased hospital costs, [9] [10] [11] and poor patient satisfaction. 12 PONV is also the most common reason for unplanned overnight stays after breast cancer surgery. 9 In addition, with the emergence of same-day surgery as the standard for most breast cancer resections, these women also experience postdischarge nausea and vomiting (PDNV) at home without nursing support. 13, 14 Patients have reported that they experience their highest level of nausea on the day of discharge after ambulatory surgery. 15 Guidelines from the American Society of Clinical Oncology indicate that the goal for treatmentinduced nausea and vomiting should be complete control. 16 However, this goal has remained elusive. Recent research has shown that nearly one-third of all women continue to experience PONV and PDNV after surgery for breast cancer, despite adherence to appropriate antiemetic guidelines. 17 Well-established risk factors have been identified that increase the risk of PONV and PDNV. They include the use of opioids for postoperative pain, 18 female gender, a negative smoking history, and history of PONV or motion sickness. 8, [19] [20] [21] In addition, some studies have found preoperative psychological factors, including anxiety and distress, increase the severity of PONV for women with breast cancer. 22 
Purpose
The purpose of this prospective study was to assess the incidence and risk factors associated with PONV and PDNV from preoperative to 48 hours postoperatively in women scheduled for breast cancer surgery.
Methods

Design
This study, which was approved by the University of Pittsburgh Institutional Review Board, used a prospective comparative design to compare women with breast cancer who experienced nausea and vomiting after surgery with women with breast cancer who did not. Women who were diagnosed with breast cancer and were scheduled for surgery were evaluated for incidence of vomiting as well as the presence and severity of nausea.
To be eligible for the study, women were diagnosed with early stage breast cancer (stage I, II, and IIIA) and scheduled for surgical resection of their cancer under general anesthesia or combined general and regional anesthesia. Only women with an American Society of Anesthesiologists physical status of I, II, or III were included, and because the study design included follow-up telephone calls after discharge, they also had to have access to a telephone. Exclusion criteria included having breast reconstruction surgery (because of length of anesthesia time) or any history of neurologic conditions such as stroke, head injury, spinal cord injury, and intracerebral hemorrhage, which could also be the cause of nausea. Given the planned objectives of the study, a sample of 100 was estimated to yield parameter estimation with margin of error (in terms of the half-width of the confidence interval [ After receiving institutional review board approval, recruitment and initial data collection took place in the preoperative holding area of a large women's hospital, which houses a Comprehensive Breast Care Program. The study team conferred with the attending surgeon and or members of the surgical team each morning to review the operating room (OR) schedule and determine if patients who met the study criteria were scheduled for surgery. Potential participants were approached by a member of the clinical team to assess interest in the study. The principal investigator provided patients, who indicated interest, a description of the study, and if they agreed to participate, informed consent was obtained.
Study Variables and Data Collection
PREOPERATIVE DATA COLLECTION. Individual characteristics, including age, race, smoking history, history of PONV, and motion sickness, were collected from the patient in the preoperative holding area after informed consent was obtained. Preoperative distress was measured using the tension-anxiety subscale of the short form of the Profile of Mood States. 23, 24 The tension-anxiety subscale has six items (mood words), which are rated on a Likert-type scale ranging from 0 (not at all) to 4 (extremely). The score is the sum of the responses for the six items. This scale has demonstrated validity and reliability in women with breast cancer, 25 with excellent internal consistency (Cronbach alpha 5 0.91). 22 POSTOPERATIVE DATA COLLECTION. The outcome variables for this study were PONV and PDNV, or more specifically postoperative and postdischarge vomiting, as well as postoperative and postdischarge nausea. Vomiting was assessed both as a nominally scaled binary variable (yes/no) and as a continuous variable to measure the number of separate emetic events. Nausea was measured on a verbal numeric 11-point Numeric Nausea Scale, with 0 being the absence of nausea and 10 being the highest level of nausea ever experienced. PONV data were collected continuously until completion of both phases of recovery. In our previous work, we found that patients in the PACU were not able to record their nausea on a visual analog scale but were able to respond verbally to the Numeric Nausea Scale. Cork et al 26 reported equivalence in reliability and validity when comparing a verbal response to a visual analog scale.
Pain was measured on an analogous verbal numeric 11-point pain scale. The amount and type of antiemetic and/or pain medications administered were abstracted from patient records. In addition, the type of surgery, surgical time, anesthetic agents, and medications administered in the OR were collected.
48 HOURS AFTER SURGERY. Participants were telephoned at home to assess for reoccurring or new PDNV 48 hours after surgery, using the same measures as used for the postoperative evaluation. Subjects who were still hospitalized were assessed in person. Discharged patients were asked to keep track of the amount and type of antiemetic and pain medications taken, and those data were collected via the phone call in addition to the assessment of PDNV and pain.
Data Analysis
Data were analyzed using IBM SPSS Statistics 23.0 (IBM Corporation, Armonk, NY). Given the level of measurement of the descriptor and its observed data distribution, appropriate descriptive statistics were computed to describe the total sample and groups based on PONV and PDNV status. In particular, the percentage of women having experienced PONV and PDNV was estimated and reported with 95% CIs. In addition, univariate binary logistic regression was used to identify risk factors for PONV and PDNV and to compute crude (unadjusted) odds ratios with 95% CIs. The level of statistical significance for two-sided hypothesis testing was set at .05.
Findings
In total, the sample consisted of 97 women with early stage breast cancer who were recruited before surgery. The sample characteristics are presented in Tables 1 and 2 . Eighty-eight women (92%) were white, 84 (88%) were nonsmokers, and 48 (50%) had a positive history of PONV. The type of surgery for most women was a modified partial or segmental mastectomy (55%), with 21 women (22%) having full mastectomies. All patients were administered ondansetron, and all but five were also administered dexamethasone while still in the OR as a prophylaxis for PONV. In addition, 13 patients (14%) had a scopolamine patch placed, and seven patients were administered an oral substance-P antagonist before the OR, while still in the preoperative holding area. 
Postoperative Nausea and Vomiting
Twenty-nine (29.8%) women experienced nausea, and nine (9%) women experienced nausea and vomiting while in the PACU. The mean nausea intensity score for those women who reported nausea in the PACU was 6.34 6 2.65, with a range from 2 to 10. The study sample characteristics based on PONV status are presented in Table 1 . Using two-sample t tests, we compared women who experienced PONV with those who did not experience PONV and found that women with PONV had significantly higher verbal pain scores (P 5 .003) and received a greater amount of total opioids (P 5 .001) than those women who did not experience PONV. Using the chi-square test of independence, a history of previous PONV was found to be significantly more common (P 5 .001) in the group with PONV compared with those with no PONV; smoking levels were similar between groups based on PONV status. In addition, a trend was found for women with PONV reporting higher anxiety scores as measured by the short form of the Profile of Mood States (P 5 .08).
Forty-one (40%) women in this study received intravenous (IV) acetaminophen (Figure 1 ). There was no significant difference in the incidence of PONV between women who received IV acetaminophen and those who did not receive IV acetaminophen. The average pain score for the women who received IV acetaminophen was significantly higher (P 5 .01) as was the amount of opioids received in the PACU (P 5 .022).
Postdischarge Nausea and Vomiting
Findings for PDNV were slightly different than for PONV ( 
Discussion
The primary goal for this prospective study was to describe the variability of nausea and vomiting from presurgery to 48 hours postdischarge from the PACU in women undergoing surgery for early stage breast cancer. Consistent with most PONV studies, we found a history of PONV to be a highly Figure 1 . Comparison of verbal postanesthesia care unit (PACU) pain scores, verbal nausea scores for those women who experienced nausea, and amount of opioids in morphine equivalents, given in the PACU for those women who received intravenous (IV) acetaminophen and those who did not after their surgery for breast cancer. This figure is available in color online at www.jopan.org. significant predictor of PONV. 27 Smoking is also a well-established risk factor for PONV 27 but was not significantly different between women with and without PONV in this study, perhaps because of the low number of smokers in the sample. There were only 12 current smokers in this sample, and although 8 of the 12 did not experience nausea or vomiting, the numbers were not high enough to influence the results.
It is not surprising that pain scores and thus the increased need for postoperative opioids were also significantly higher in the women who experienced PONV; both are established risk factors that have been well documented. 3, 27, 28 Also consistent with previous research is the fact that this study found that nausea was more prevalent than vomiting. 29 The addition of preoperative antiemetic medication as recommended for high-risk patients, 30 either an oral neurokinin-1 or a scopolamine patch, was effective half of the time that they were used. Certainly, the clinical guidelines 30 suggest we would find that the addition of another antiemetic to the standing order of ondansetron/ dexamethasone in high-risk patients should decrease the risk for PONV. 27 Our findings regarding the 41 women who received IV acetaminophen group after their surgery are not consistent with other studies, 31 as IV acetaminophen has been reported to decrease postoperative pain and postoperative opioids, and then consequently PONV.
The trend (P 5 .08) toward women with PONV to report higher levels of preoperative anxiety is consistent with the findings of Montgomery et al. 22 In that study however, anxiety was assessed at the physician's office before surgery, which may be a more predictive time than immediately before surgery. It will be of interest in future research to explore the possibility that anxiety levels on the day of surgery may be less of a problem because at that time clinical decisions are already made, and the women have had a chance to live with the diagnosis for some time.
More women experienced PDNV than PONV, although the mean score for the severity of nausea was higher while women were in the hospital. As for women with PONV, opioids taken over 48 hours and average postdischarge pain scores were significantly higher for the women with PDNV than for the women without PDNV. Our finding that 13 women who did not have PONV while in the PACU subsequently experienced PDNV after leaving the hospital underscores the importance of patient discharge teaching regarding these symptoms. One situation that was described multiple times by patients during the follow-up phone conversation was the fact that before discharge, women received an oral opioid for pain, then got in the car to drive home, basically on an empty stomach, and in one patient's words ''threw-up the whole way home.'' Also interesting was the number of women who did not report PDNV at the time of the 48-hour postoperative phone call. Yet, when questioned about pain, 11 women reported that they did not fill their pain medication prescriptions after discharge because of previous postoperative experience of nausea, choosing in one patient's words, ''to deal with the pain instead of having to deal with that awful nausea.'' This preference was not uncommon, with 13 women who did not experience PDNV reporting that they would choose pain over nausea. This information was not solicited with a question but was a fairly frequent response during the follow-up phone call when patients were asked about opioids they might have taken for pain.
Race has not been found in most studies to be a significant predictor of nausea and vomiting. 27 However, our finding that none of the women of African American descent in our study experienced nausea or vomiting at home is consistent with two published articles. 32, 33 One report found that white children had more side effects from smaller amount of opioids than their African American counterparts, whereas another report from South Africa suggested the need for a modified risk score because of decreased frequency of PONV in Black African patients. 32, 33 Certainly, more research is needed to understand racial and ethnic differences in these symptoms.
Limitations
We conducted this study in a single center, and practices with regard to the administration of preoperative and postoperative medications may have influenced the occurrence of PONV and PDNV. In addition, because of the small number of subjects who were not Caucasian, our findings cannot be generalized to other racial/ethnic groups. A larger study is planned to increase the ethnic and racial diversity of subjects included to better describe the experience of PONV and PDNV in all women after breast cancer surgery.
Conclusion
Although PONV and PDNV are recognized as continuing problems in need of clinical management, our ability to prevent these troublesome symptoms, especially nausea, appears to be limited. A recent article noted that ''we have currently reached the point of knowing a lot, but doing too little for our patients and that implementation of evidence-based guidelines should be the major goal regarding PONV for the next decade.'' 34 Although clinical guidelines may be helpful, our observation is that nurses in the PACU setting are already continuously challenging themselves to individualize the combination of medications and activities for each patient to reduce PONV after surgery for breast cancer. Future research to better control PONV and PDNV should be directed toward new prevention and treatment strategies grounded in a better understanding of the underlying biology of nausea and vomiting in the surgical setting.
